학술논문

Framework to Diagnose the Metabolic Syndrome Types without Using a Blood Test Based on Machine Learning
Document Type
article
Source
Applied Sciences, Vol 10, Iss 23, p 8404 (2020)
Subject
metabolic syndrome
Quine–McCluskey algorithm
SMOTE
artificial neural networks
random undersampling boosted tree
diagnostic non-invasive
Technology
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
Language
English
ISSN
2076-3417
Abstract
Metabolic Syndrome (MetS) is a set of risk factors that increase the probability of heart disease or even diabetes mellitus. The diagnosis of the pathology implies compliance with at least three of five risk factors. Doctors obtain two of those factors in a medical consultation: waist circumference and blood pressure. The other three factors are biochemical variables that require a blood test to determine triglyceride, high-density lipoprotein cholesterol, and fasting plasma glucose. Consequently, scientists are developing technology for non-invasive diagnostics, but medical personnel also need the risk factors involved in MetS to start a treatment. This paper describes the segmentation of MetS into ten types based on harmonized Metabolic Syndrome criteria. It proposes a framework to diagnose the types of MetS based on Artificial Neural Networks and Random undersampling Boosted tree using non-biochemical variables such as anthropometric and clinical information. The framework works over imbalanced and balanced datasets using the Synthetic Minority Oversampling Technique and for validation uses random subsampling to get performance evaluation indicators between the classifiers. The results showed an excellent framework for diagnosing the 10 MetS types that have Area under Receiver Operating Characteristic (AROC) curves with a range of 71% to 93% compared with AROC 82.86% from traditional MetS.